iTernity and Biomedion Join Forces to Deliver Industry-Leading Archiving Solutions

iTernity GmbH, a provider of enterprise-grade software-defined storage (SDS) archiving infrastructure merges with biomedion GmbH, a German specialist in GxP-compliant data management software for the pharmaceutical industry. Through the combination, iTernity adds expertise in the highly regulated pharmaceutical vertical, while maintaining its broader focus of being a sector agnostic data management solution provider.Founded in 2004 and headquartered in Freiburg, Germany, iTernity develops software-defined storage for archiving and backups that ensure long-term data protection and regulatory compliance. Its flagship products, iCAS and iCAS FS, are deployed by over 1,400 international customers across healthcare, automotive, public sector, pharma, and industrial verticals. The company’s partner-led sales model and scalable software architecture have contributed to strong growth and customer retention. The management team from iTernity – Armin Weißer and Tobias Neerfeld – remains committed and will stay onboard for the company’s next growth chapter.

The merger combines biomedion’s expertise in GxP-compliant data archiving with exclusive focus on the pharmaceutical industry with iTernity’s enterprise-grade SDS infrastructure. biomedion’s flagship platform, Watcher, automates the secure storage of raw laboratory data in highly regulated environments. iTernity’s solutions, including iCAS and ICAS FS, offer scalable, tamper-proof archiving across a wide range of industries. Together, the companies now offer a comprehensive and modern software suite consisting of:

ICAS and ICAS FS – horizontal archiving solutions for enterprise-wide compliance and data protection as well as
Watcher – a specialized platform focusing on data integrity and archiving in the pharmaceutical industry

The newly formed group is powered by a team of experienced professionals with deep industry knowledge. Their unified offering strengthens data integrity, supports regulatory compliance, and ensures audit readiness for customers across sectors.

“This acquisition embodies a strategic milestone towards our ambition of building a leading European software group within data management and archiving solutions,” said Eike Eul, investment director, Main Capital Partners.

“Joining forces with biomedion marks an important step in iTernity’s evolution. We share a strong commitment to data integrity and compliance, and together we can deliver broader, more integrated solutions to our customers. This partnership opens new opportunities for innovation, growth, and long-term value for our clients and partners,” added Armin Weißer, CEO, iTernity.

“We are pleased to collaborate with iTernity in a broader group setting. Their expertise in scalable archiving and data protection complements our strengths in regulated data management. By combining our capabilities, we can offer a more complete platform that meets the increasing demands of compliance, data volume, and operational resilience,” concluded Andreas Hepfner, CEO, biomedion.